Orthopedic Biomaterial Market Revenue, Company Profile, Key Trend Analysis & Forecast Till 2027


The orthopedic Biomaterials Market is expected to register a CAGR of 10.5% during the forecast period 2020-2027, to reach USD 40,519.52 million by 2027.

MRFR recognizes the following companies as the key players in the global orthopedic Biomaterials Market—Stryker (US), CoorsTek Inc (US), Zimmer Biomet Holdings Inc (US), Institute Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith & Nephew (UK),3M (US), Nobel Biocare Services AG(Switzerland), Medtronic (Ireland), and DePuy Synthes (US).

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/415

Market Highlights

The global orthopedic biomaterials market is expected to have a value of USD 40,519.52 million by 2027.

Orthopedic biomaterials are implanted in the human body as constituents. These devices perform certain biological functions by substituting different tissues such as bone, cartilage, ligaments, and tendons, and even guiding bone repair when necessary. Orthopedic biomaterials are generally chosen for their strength and imitating the bone structure. They also promote the mineralization of tissue around the implants, which calls for bioactive material. The commonly used bioactive material calcium phosphate ceramics, particularly synthetic hydroxyapatite (HA), closely resemble bone apatite and have been developed for bone tissue repair. Increased occurance of musculoskeletal disorders and chronic skeletal disorders increases product demand, which has boosted the demand for orthopedic biomaterial, thereby accelerating market growth. A rising senior population is anticipated todrive the demand for orthopedic biomaterials further.

Segment Analysis

The global orthopedic biomaterials market has been segmented in to product, material, application, and end user. The global market, by product, has been segmented into reconstructivejoint replacement, spinal implants, dental implants, trauma, and orthobiologics. Reconstructive joint replacements are further sub-segmented into knee replacement implants, hip replacement implants, and extremities. Spinal implants are further sub-segmented into spinal fusion implants, Vertebral Compression Fracture (VCF) devices, and motion preservation devices/non-fusion devices. Dental implants are sub-segmented into root form and plate form dental implants. Orthobiologics are further sub-segmented into viscosupplementation, demineralized bone matrix, synthetic bone substitutes, bone morphogenetic protein, allograft, and others. On the basis of material, the market is divided intometal and non-metal.The metal is further segmented into stainless steel, titanium alloy, cobalt alloy. The non-metal is further bifurcated into ceramic and polymeric. The ceramic is sub-segmented into alumina, calcium phosphate, zirconium dioxide and carbon. The polymeric is further sub-segmented into polymethylmethacrylate (PMMA), polyethylene, silicone, polyester. On the basis of application, the market is bifurcated intojoint replacement, fracture fixation, tissue fixation, implant surgery, viscosupple mentation. The joint replacement is segmented into hip replacement, knee replacement, shoulder, and elbow replacement. On the basis of end users, the market is bifurcated into hospitals & clinics, andambulatory surgical centers.

Regional Analysis

The global orthopedic biomaterials market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas dominatedthe market in 2019 and is likely to continue to command during the assessment period. This is due to the high prevalence of orthopedic disorders, new product launches, and technological advancement in this region. The high demand for orthopedic biomaterials and the availability of skilled professionals in the region are expected to fuel the regional market growth. The growing elderly population is also resulting in the growth of the orthopedic biomaterials market in the Americas. As per the Administration for Community Living (US), in the Americas, over the last ten years, the population aged 65 and over grew from 37.2 million in 2006 to 49.2 million in 2016. Hence, a large patient pool suffering from orthopedic ailments, rapid adoption of advanced products, and a growing geriatric population are expected to boost the growth of the orthopedic biomaterials market in the Americas during the study period.

The European orthopedic biomaterials market has been divided into Western Europe and Eastern Europe. The Western European orthopedic biomaterials market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Europe is the second-largest region in the orthopedic biomaterial market to witness significant growth during the forecast period due to a higher number of patients and the easy availability of products in the region. In 2017, Switzerland, Finland, Luxembourg, Germany, Austria, and Belgium were among the countries with the highest hip and knee replacements in the region. The Organisation for Economic Co-operation and Development (OECD) averages are 182 per 100,000 for hip replacements and 135 per 100,000 for knee replacements. Since 2000, the number of hip and knee replacement procedures has increased rapidly in most OECD countries. On average, hip replacement rates increased by 30% between 2007 and 2017, and knee replacement rates by 40%. This increase in the number of patients undergoing knee and replacement is anticipated to boost the regional market growth.

The orthopedic biomaterials market in the Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Asia-Pacific region is expected to register the highest growth rate in the market. In Asia-Pacific, the population of people aged 65 and above is expected to grow dramatically over the next 50 years. For the region, the population in this age group will increase by 31.4%, from 207 million in 2000 to 857 million in 2050. A large number of adults residing in the region are expected to suffer from various orthopedic disorders. Moreover, the increasing per capita disposable income of middle-class families, which accounts for a large population in Asia, results in individuals spending more on health.

The Middle East & Africa orthopedic biomaterials market is segmented into the Middle East and Africa. The key factors propelling the regional market's growth are the increasing the prevalence of orthopedics disorders and funding by private players and government bodies. As per the International Trade Administration report, the Saudi healthcare sector is the largest in the Middle East. Saudi Arabia's health and social affairs budget for 2019 shows an 8% increase to USD 46 billion compared to USD 42.4 billion in 2018.

Key Findings of the Study

  • The global orthopedic biomaterials market is predicted to reachUSD 40,519.52 million by 2027 at a CAGR of 7.5% during the assessment period of 2020 to 2027.
  • The Americas accounted for the largest share of the global orthopedic biomaterials marketdue to prominent players in the US, the high prevalence of orthopedic diseases, and rising healthcare expenditure.
  • By product, the reconstructive joint replacement segment accounted for the largest market share of 32.0%in 2019.
  • On the basis of material, the market is divided intometal andnon-metal. The metal segment is likely to dominate the market at a CAGR of 6.93% during the forecast period of 2020-2027.
  • Based on application, thejoint replacement segment is projected to exhibit a CAGR of 7.78%during the forecast period 2020-2027.
  • Based on end user, the hospitals & clinics segment is expected to dominate the market with a share of 46.37% during the forecast period.
  • Some of the key players operating in the orthopedic biomaterials market are Stryker (US), CoorsTek Inc. (US), Zimmer Biomet Holdings Inc (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith & Nephew (UK),3M (US), Nobel Biocare Services AG(Switzerland), Medtronic (Ireland), and DePuy Synthes (US).

Access full report @ https://www.marketresearchfuture.com/reports/orthopedic-biomaterial-market-415

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Have a Look at Related Reports:

Life Science Analytics Market

ACE Inhibitors Market

Aortic Valve Market

Somatostatin Analogs Market

Lymphedema Diagnostics Market

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com


Comments

Post a Comment

Popular posts from this blog

ICP-OES Spectrometer Industry Size, Share, Key Players, Growth Trend, and Forecast Till 2030

Image
  The global  ICP-OES Spectrometer Industry  was valued at USD 521.4 million in 2018 at a CAGR of 7.2% during the forecast period of 2019 to 2025. ICP-OES Spectrometer is an analytical instrument that is used for the detection of chemical elements. It uses the technique of inductively coupled plasma optical emission spectroscopy (ICP-OES) for carrying out its analysis procedure. Certain factors that propel the growth of the ICP-OES Spectrometer Industry include increasing R&D expenditure for the development of better analytical systems and growing technological advancements. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8120 However, the high cost of instruments and requirement of large capital investment for setting up instrument manufacturing plants is hindering the growth of the global ICP-OES Spectrometer Industry in the forecast period. Currently, the global ICP-OES Spectrometer Industry is dominated by several players. ...
Read more

Opioid Withdrawal Treatment Market Growth, Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2030

Image
The global  opioid withdrawal treatment growth market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8123 Segmentation The global opioid withdrawal treatment market has been segmented into drug type and distribution channel. By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, a...
Read more

Preclinical Imaging Market Trends, Size, Key Factors, Major Players, Growth Strategies, Forecast Till 2027

Image
Preclinical Imaging Market Trends , Revenue Forecast, Competitive Landscape, Growth Factors, and Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging. Requ...
Read more